Changhua Ji

Changhua Ji

Auto-generated profile, based on publicly available information

Changhua Ji

Affiliation Drug Safety Research and Development, Pfizer Inc, San Diego, California, United States of America

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
CJChanghua Ji
Changhua Ji
MRMarc D. Roy
Marc D. Roy
JGJonathan Golas
Jonathan Golas
AVAllison Vitsky
Allison Vitsky
SRSripad Ram
Sripad Ram
BBBernard S. Buetow
Bernard S. Buetow
Purpose: Immune checkpoint inhibitors (ICI) targeting PD1, PDL1, or CTLA4 are associated with immune-related adverse events (irAE) in multiple organ systems including myocarditis. The pathogenesis and early diagnostic markers for ICI-induced myocarditis are poorly understood, and there is currently a lack of laboratory animal model to enhance our understanding. We aimed to develop such a model using cynomolgus monkeys. Experimental Design: Chinese-origin cynomolgus monkeys were dosed intravenously with vehicle or nivolumab 20 mg/kg plus ipilimumab 15 mg/kg once weekly and euthanized on day 29. Results: Multiple organ toxicities were observed in cynomolgus monkeys, and were characterized by loose feces, lymphadenopathy, and mononuclear cell infiltrations of varying severity in heart, colon, kidneys, liver, salivary glands, and endocrine organs. Increased proliferation of CD4+ and CD8+ T lymphocytes as well as an increase in activated T cells and central memory T cells in the blood, spleen, and lymph nodes, were observed. Transcriptomic analysis suggested increased migration and activation of T cells and increased phagocytosis and antigen presentation in the heart. Mononuclear cell infiltration in myocardium was comprised primarily of T cells, with lower numbers of macrophages and occasional B cells, and was associated with minimal cardiomyocyte degeneration as well as increases in cardiac troponin-I and NT-pro-BNP. Morphologically, cardiac lesions in our monkey model are similar to the reported ICI myocarditis in humans. Conclusions: We have developed a monkey model characterized by multiple organ toxicities including myocarditis. This model may provide insight into the immune mechanisms and facilitate biomarker identification for ICI-associated irAEs.

1 August 2016 in Antiviral Research
Verified
Journal Article
Closed access
DCDawei Cai
Dawei Cai
XWXiaohe Wang
Xiaohe Wang
RYRan Yan
Ran Yan
RMRicheng Mao
Richeng Mao
YLYuanjie Liu
Yuanjie Liu
HGHAITAO GUO
HAITAO GUO

20 September 2019 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
CJChanghua Ji
Changhua Ji
MGMausumee Guha
Mausumee Guha
XZXu Zhu
Xu Zhu
JWJessica Whritenour
Jessica Whritenour
MHMichelle D. Hemkens
Michelle D. Hemkens
ROR. Scott Obach
R. Scott Obach

21 May 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TATimothy Affolter
Timothy Affolter
HLHeather P Llewellyn
Heather P Llewellyn
DBDerek W Bartlett
Derek W Bartlett
QZQing Zong
Qing Zong
SXShuhua Xia
Shuhua Xia
CJChanghua Ji
Changhua Ji
Cancer cells harness immune checkpoints such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death protein 1 (PD-1) and indoleamine 2,3-dioxygenase 1 (IDO1) to evade immune control. Checkpoint inhibitors have demonstrated durable anti-tumor efficacy in human and preclinical models. Liver toxicity is one of the common immune-related adverse events associated with checkpoint inhibitors (CPIs) and its frequency and severity often increase significantly during CPI combination therapies. We aim to develop a mouse model to elucidate the immune mechanisms of CPI-associated liver toxicity. Co-administration of CTLA-4 blocking antibody, 9D9, and/or an IDO1 inhibitor, epacadostat in wild-type and PD-1-/- mice (to simulate the effect of PD1 blockade) synergistically induced liver injury and immune cell infiltration. Infiltrated cells were primarily composed of CD8+ T cells and positively associated with hepatocyte necrosis. Strikingly, sites of hepatocyte necrosis were frequently surrounded by clusters of mononuclear immune cells. CPI treatments resulted in increased expression of genes associated with hepatocyte cell death, leukocyte migration and T cell activation in the liver. In conclusion, blockade of immune checkpoints PD-1, CTLA-4, and IDO1 act synergistically to enhance T cell infiltration and activity in the liver, leading to hepatocyte death.

1 November 2021 in Journal of Hepatology
Verified
Journal Article
Closed access
HLHeather P. Llewellyn
Heather P. Llewellyn
SASeda Arat
Seda Arat
JGJingjin Gao
Jingjin Gao
JWJi Wen
Ji Wen
SXShuhua Xia
Shuhua Xia
CJChanghua Ji
Changhua Ji

28 February 2024 in Veterinary Immunology and Immunopathology
Verified
Journal Article
Closed access
XZXu Zhu
Xu Zhu
KRKara Rogers
Kara Rogers
CBChristine Bono
Christine Bono
ZWZhenyu Wang
Zhenyu Wang
CDCarol Donovan
Carol Donovan
CJChanghua Ji
Changhua Ji